| 英文品名 |
inotuzumab ozogamicin |
| 名称来源 |
p-INNList-92,2004;r-INNList-54,2005; |
| 别 名 |
CMC-544, WAY-207294 |
| 化学表述 |
immunoglobulin G4, anti-(human CD22 (antigen)) (human-mouse monoclonal G544 heavy chain), disulfide with human-mouse monoclonal G544 κ-chain, dimer, conjugate with methyl N-{(1R,4Z,8S,13E)-8-(4,6-dideoxy-4-{[(4-S-{4-[(6-deoxy-3-O-methyl-4-thio-β -D-ribo-hexopyranosyl)oxy]amino}-2-O-[4-(N-ethylacetamido)-2,4-dideoxy-3-O-methyl-α-L-threo-entopyranosyl]-β-D-glucopyranosyloxy)-13-[2-({4-[2-(1-{[4-(4-amino-4-oxobutyl)oxy]phenyl}ethylidene)hydrazinyl]-2-methyl-4-oxobutan-2-yl}disulfanyl)ethylidene]-1-hydroxy-11-oxobicyclo[7.3.1]trideca-4,9-diene-2,6-diyn-10-yl}carbamateα-L-mannopyranosyl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzoyl}- |
| CA登记号 |
635715-01-4 |
| 分 子 式 |
C6518H10002N1738O2036S42 |
| 结 构 式 |
|
| 品种类别 |
抗肿瘤药>单克隆抗体类; antineoplastic; |
| 简介 |
上市（Wyeth，美国）。Oncological treatment |
|
